Oncolytics Biotech (ONC) News Today C$1.44 +0.02 (+1.41%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period July 26 at 4:28 PM | baystreet.caIntegrated Cyber Solutions IncJuly 25 at 9:11 AM | marketbeat.comOncolytics Biotech (ONC) Set to Announce Earnings on ThursdayOncolytics Biotech (TSE:ONC) will be releasing earnings after the market closes on Thursday, August 1, Zacks reports.July 24 at 9:51 AM | theglobeandmail.comClosing Bell: Oncolytics Bio flat on Tuesday (ONC)July 23 at 11:49 PM | finanznachrichten.deBioInvent International: BioInvent to Present Pipeline Progress on BI-1910 and BT-001 at ESMOJuly 17, 2024 | marketbeat.comOncolytics Biotech (TSE:ONC) Stock Price Passes Above 200 Day Moving Average of $1.49Oncolytics Biotech (TSE:ONC) Share Price Crosses Above Two Hundred Day Moving Average of $1.49July 9, 2024 | marketbeat.comOncolytics Biotech (TSE:ONC) Share Price Passes Below Two Hundred Day Moving Average of $1.50Oncolytics Biotech (TSE:ONC) Stock Price Passes Below 200 Day Moving Average of $1.50June 11, 2024 | marketbeat.comOncolytics Biotech (TSE:ONC) Shares Cross Below 200-Day Moving Average of $1.57Oncolytics Biotech (TSE:ONC) Stock Passes Below 200-Day Moving Average of $1.57May 16, 2024 | marketbeat.comFY2024 Earnings Forecast for Oncolytics Biotech Inc. (TSE:ONC) Issued By HC WainwrightOncolytics Biotech Inc. (TSE:ONC - Free Report) - Research analysts at HC Wainwright upped their FY2024 earnings per share estimates for Oncolytics Biotech in a research note issued on Tuesday, May 14th. HC Wainwright analyst P. Trucchio now anticipates that the company will earn ($0.38) per sharMay 15, 2024 | marketbeat.comHC Wainwright Weighs in on Oncolytics Biotech Inc.'s FY2028 Earnings (TSE:ONC)Oncolytics Biotech Inc. (TSE:ONC - Free Report) - Equities research analysts at HC Wainwright dropped their FY2028 EPS estimates for Oncolytics Biotech in a report issued on Tuesday, May 14th. HC Wainwright analyst P. Trucchio now expects that the company will earn $0.58 per share for the year, dMay 15, 2024 | finance.yahoo.comOncolytics Biotech® Announces Preliminary Collaboration with GCAR for Inclusion of Pelareorep in Anticipated Pancreatic Cancer TrialMay 14, 2024 | markets.businessinsider.comBuy Rating Affirmed on Oncolytics Biotech’s Advancements and Prospective Partnerships in Cancer Treatment PipelineMay 11, 2024 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: Oncolytics Biotech (ONCY), Lineage Therap (LCTX)May 10, 2024 | finanznachrichten.deOncolytics Biotech Inc.: Oncolytics Biotech Reports First Quarter 2024 Financial Results and Operational HighlightsMay 9, 2024 | msn.comONCY Stock Earnings: Oncolytics Biotech Beats EPS for Q1 2024May 9, 2024 | finanznachrichten.deFN Media Group: Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expected to Exceed $36 Billion by 2036May 9, 2024 | ca.finance.yahoo.comStocks in play: Oncolytics Biotech Inc.May 9, 2024 | finance.yahoo.comOncolytics Biotech® Reports First Quarter 2024 Financial Results and Operational HighlightsMay 9, 2024 | finanznachrichten.deUSA News Group: Biotech Innovations Surge as Global Cancer Diagnosis Rates Continue to ClimbMay 8, 2024 | finance.yahoo.comOncolytics Biotech® to Participate in a Fireside Chat at the 2024 RBC Capital Markets Global Healthcare ConferenceApril 11, 2024 | ca.finance.yahoo.comStocks in play: Oncolytics Biotech® Inc.April 11, 2024 | finance.yahoo.comOncolytics Biotech® Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDAApril 10, 2024 | markets.businessinsider.comTransgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at AACR 2024April 4, 2024 | marketbeat.comOncolytics Biotech (TSE:ONC) Trading Up 10.7%Oncolytics Biotech (TSE:ONC) Trading Up 10.7%March 16, 2024 | theglobeandmail.comClosing Bell: Oncolytics Bio down on Friday (ONC)March 11, 2024 | msn.comFutures Retreat SharplyMarch 6, 2024 | finanznachrichten.deOncolytics Biotech Inc.: Oncolytics Biotech Files Amendment to Initiate New Pancreatic Cancer GOBLET Cohort Supported by PanCANMarch 6, 2024 | finanznachrichten.deEcon Corp Services DBA Investorideas.com: Biotech/Oncology Stocks Targeting the Pancreatic Cancer Market - A Race Worth WinningMarch 6, 2024 | benzinga.comA Preview Of Oncolytics Biotech's EarningsMarch 2, 2024 | morningstar.comOncolytics Biotech Inc ONCFebruary 15, 2024 | markets.businessinsider.comReiterating Buy Rating: Expanding Potential of Pelareorep in Oncolytics Biotech’s PipelineFebruary 15, 2024 | finance.yahoo.comCancer Immunotherapy Stocks - Tapping into Immune Systems for Next Generation TreatmentsFebruary 14, 2024 | theglobeandmail.comAnal Cancer Treatment Market Expected to Reach $1.63 Billion by 2030 as Latest Clinical Studies Focus on New TherapiesFebruary 7, 2024 | finanznachrichten.deUSA News Group: Pancreatic Cancer Treatments Poised for Major Advances in 2024February 6, 2024 | marketbeat.comOncolytics Biotech (TSE:ONC) Trading Down 7.1%Oncolytics Biotech (TSE:ONC) Stock Price Down 7.1%January 31, 2024 | finance.yahoo.comKaliVir Announces Opening of GMP Cleanroom Facility, Increasing Manufacturing Capacity for Oncolytic VirusesJanuary 6, 2024 | benzinga.comOncolytics Biotech Stock (NASDAQ:ONCY), Analyst Ratings, Price Targets, PredictionsDecember 14, 2023 | markets.businessinsider.comJonesTrading Keeps Their Hold Rating on TRACON Pharmaceuticals (TCON)December 7, 2023 | finanznachrichten.deOncolytics Biotech Inc.: Oncolytics Biotech® and SOLTI Present Positive Translational Data at SABCSNovember 9, 2023 | finance.yahoo.comOncolytics Provides Update on Pancreatic Cancer Program for PelareorepNovember 3, 2023 | benzinga.comOncolytics Biotech's Earnings OutlookNovember 3, 2023 | finanznachrichten.deOncolytics Biotech Inc.: Oncolytics Biotech Reports Third Quarter 2023 Financial Results and Operational HighlightsNovember 3, 2023 | finanznachrichten.deOncolytics Biotech Inc.: Oncolytics Biotech® and SOLTI Present Further Positive Pelareorep Translational Data at SITCNovember 3, 2023 | finance.yahoo.comOncolytics Biotech® and SOLTI Present Further Positive Pelareorep Translational Data at SITCNovember 3, 2023 | msn.comOncolytics Biotech GAAP EPS of -$0.14 misses by $0.06November 3, 2023 | finance.yahoo.comOncolytics Biotech® Reports Third Quarter 2023 Financial Results and Operational HighlightsOctober 23, 2023 | marketwatch.comOncolytics Shares Rise 9.3% as Data Presented From Pancreatic Cancer StudyOctober 20, 2023 | finanznachrichten.deUSA News Group: Biotech Companies Make Further Progress in Promising Pancreatic Cancer Treatment ResearchOctober 20, 2023 | finanznachrichten.deOncolytics Biotech® Inc.: Oncolytics Biotech® to Host Conference Call to Discuss Third Quarter Financial Results and Recent Operational HighlightsSeptember 28, 2023 | ca.finance.yahoo.comStocks in play: Oncolytics Biotech, Inc.September 22, 2023 | baystreet.caPioneering the Path to Cure Cancer: 2023's Biotech Innovations Get Oncolytics Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for ONC and its competitors with MarketBeat's FREE daily newsletter. Email Address J.P. Morgan’s DIRE Warning (Ad)When the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal warns, "America's bonds are getting harder to sell." Click here to see why Wall Street is in PANIC mode >>> ONC Media Mentions By Week ONC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ONC News Sentiment▼0.280.62▲Average Medical News Sentiment ONC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ONC Articles This Week▼41▲ONC Articles Average Week Get Oncolytics Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for ONC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Fennec Pharmaceuticals News Medicenna Therapeutics News Theratechnologies News Sernova News Covalon Technologies News Small Pharma News Microbix Biosystems News IBEX Technologies News Kane Biotech News Ceapro News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:ONC) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredNEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands o...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oncolytics Biotech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncolytics Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
